World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5078)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

136

HTML

2851

Figures (1-1)

448

Tables (1-5)

422

Sum=3857

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

156

Download

893

Sum=1049

Jun 26, 2024 (publication date) through Feb 26, 2026

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Lin MJ, Zou SB, Zhu BX. Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia. World J Clin Cases 2024; 12(18): 3468-3475 [PMID: 38983399 DOI: 10.12998/wjcc.v12.i18.3468]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i18/3468.htm

Number	Citing Articles
1	Bart J. van Essen, Daan C.H. Ceelen, Wouter Ouwerkerk, Tiew-Hwa K. Teng, Ganash N. Tharshana, Fook Ming Hew, Javed Butler, Faiez Zannad, Carolyn S. Lam, Justin Ezekowitz, Adriaan A. Voors, Jasper Tromp. Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction. JACC 2025; 86(24): 2513 doi: 10.1016/j.jacc.2025.08.054
2	Koji Suzuki, Sumika Osa, Shunya Takeshita, Makoto Noda, Tatsuya Yagi, Yuichiro Maekawa, Junichi Kawakami. Additive Effects of Angiotensin Receptor–Neprilysin Inhibitors and Sodium–Glucose Cotransporter 2 Inhibitors on Neurohormonal Inhibition Therapy in Severe HFrEF: A Systematic Review and Network Meta-analysis. American Journal of Cardiovascular Drugs 2026; doi: 10.1007/s40256-025-00784-3
3	Claudio Borghi, Federica Fogacci, Arrigo FG Cicero. Crystal clear – Part II: the role of uric acid in cardiorenal disease. European Journal of Internal Medicine 2025; 142: 106554 doi: 10.1016/j.ejim.2025.106554
4	Xiao-Peng Fu. Dual benefits of sodium-glucose cotransporter 2 inhibitors in metabolic diseases: Diabetes control and gout management. World Journal of Clinical Cases 2025; 13(14): 100262 doi: 10.12998/wjcc.v13.i14.100262 Abstract(431) \| Core Tip(410) \| Full Article(HTML)(1282) \| Full Article with Cover (PDF)-524K(102) \| Audio-661K(18) \| Peer-Review Report-220K(80) \| Answering Reviewers-105K(89) \| Full Article (PDF)-338K(125) \| Full Article (XML)-33K(106) \| Times Cited (0) \| Total Visits (3616) \| Open
5	Yi-jiao Men, Yan-ling Dong, Yu Gong, Ya-qing An, Hong-bo Cheng. Combining clinical markers can predict mortality in NYHA IV heart failure. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-13274-y